Call Options Transactions Made in Q4 2023 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q4 2023. The information is specifically focused on institutions that hold call options of Celldex Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
CALL |
15.7K+ 15.7% |
$355K - $638K
|
116K
$2.98M
|
|
Feb 02, 2024
Q4 2023
|
Xr Securities LLC
|
BUY
|
CALL |
5.2KNew |
$118K - $211K
|
5.2K
$134K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
3.8K+ 475.0% |
$85.9K - $154K
|
4.6K
$119K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
3.6K+ 112.5% |
$81.4K - $146K
|
6.8K
$175K
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-3.8K- 5.18% |
$85.9K - $154K
|
69.5K
$1.79M
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-50.3K- 26.76% |
$1.14M - $2.04M
|
138K
$3.55M
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-85K- 42.5% |
$1.92M - $3.46M
|
115K
$2.97M
|